Literature DB >> 3383134

Prognostic significance of DNA measurements in 409 consecutive breast cancer patients.

A G Fallenius1, G U Auer, J M Carstensen.   

Abstract

Four hundred nine consecutive breast cancer patients were studied retrospectively. Microspectrophotometric DNA measurements were performed using archival, fine-needle slide preparations upon which the primary diagnoses had been based 8 to 13 years earlier. The DNA distribution patterns of the tumor cell populations were analyzed according to various criteria and the cytochemical data were correlated to the clinical course, defined as distant recurrence-free survival. The results demonstrated a strong relationship between nuclear DNA content of the breast cancer cells and prognosis. Tumors exhibiting DNA values within the limits of normal tissues (DNA euploidy) were found to be correlated with a favorable prognosis. In contrast, tumors with increased and scattered DNA values (DNA aneuploidy) were found indicative of poor prognosis. This was found to be the case regardless whether the percentage of cells above 2.5c or 5c, DNA index/modal value, or the histogram typing according to Auer et al were utilized to discriminate low-grade from high-grade malignant cases. All of these DNA variables were also shown to be significantly correlated. With the aid of the Cox regression method, the additional prognostic value of any given variable was tested against the others. The statistical analyses showed that the histogram typing gives significant prognostic information in addition to that provided by any other variable. In conclusion, the current study demonstrates that tumor nuclear DNA content is a strong indicator of prognosis in patients suffering from invasive breast adenocarcinoma. However, the results also show that simple determination of the stemline position is not the optimal DNA measure of intrinsic tumor malignancy potential. The fraction of cells scattered outside the modal peaks of the histograms are of utmost importance for adequate cytochemical malignancy grading in breast carcinomas.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3383134     DOI: 10.1002/1097-0142(19880715)62:2<331::aid-cncr2820620218>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  40 in total

1.  Proliferative activity of intratumoral fibroblasts is closely correlated with lymph node and distant organ metastases of invasive ductal carcinoma of the breast.

Authors:  T Hasebe; S Sasaki; S Imoto; A Ochiai
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

2.  Quantitative nuclear DNA content in fine needle aspirates of pancreatic cancer.

Authors:  A R Weger; K S Glaser; G Schwab; D Oefner; E Bodner; G U Auer; G Mikuz
Journal:  Gut       Date:  1991-03       Impact factor: 23.059

Review 3.  Aneuploidy as a prognostic factor in breast cancer.

Authors:  A von Rosen
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

4.  Biological grading of breast cancer using antibodies to proliferating cells and other markers.

Authors:  S S Bacus; R Goldschmidt; D Chin; G Moran; D Weinberg; J W Bacus
Journal:  Am J Pathol       Date:  1989-11       Impact factor: 4.307

5.  Implications of malignant-cell DNA content for treatment of patients with pancreatic cancer.

Authors:  A L Warshaw
Journal:  Ann Surg       Date:  1991-12       Impact factor: 12.969

6.  Principles of ploidy analysis by static cytometry.

Authors:  P S Smith; I H Parkinson; A S Leong
Journal:  Clin Mol Pathol       Date:  1996-04

7.  Aneuploidy, TP53 mutation, and amplification of MYC correlate with increased intratumor heterogeneity and poor prognosis of breast cancer patients.

Authors:  Johanna Oltmann; Kerstin Heselmeyer-Haddad; Leanora S Hernandez; Rüdiger Meyer; Irianna Torres; Yue Hu; Natalie Doberstein; J Keith Killian; David Petersen; Yuelin Jack Zhu; Daniel C Edelman; Paul S Meltzer; Russell Schwartz; E Michael Gertz; Alejandro A Schäffer; Gert Auer; Jens K Habermann; Thomas Ried
Journal:  Genes Chromosomes Cancer       Date:  2018-01-09       Impact factor: 5.006

8.  Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content.

Authors:  A von Rosen; L E Rutqvist; J Carstensen; A Fallenius; L Skoog; G Auer
Journal:  Breast Cancer Res Treat       Date:  1989-01       Impact factor: 4.872

9.  DNA aneuploidy is an independent factor of poor prognosis in pancreatic and peripancreatic cancer.

Authors:  S Sciallero; W Giaretti; E Geido; L Bonelli; L Zhankui; S Saccomanno; E Zeraschi; V Pugliese
Journal:  Int J Pancreatol       Date:  1993-08

10.  Expression of the c-erbB-2 proto-oncogene product and nuclear DNA content in benign and malignant human breast parenchyma.

Authors:  H Schimmelpenning; E T Eriksson; U G Falkmer; E Azavedo; G Svane; G U Auer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.